[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342093-105":59,"doc-detail-342093-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","antipsychotic-use-and-risk-of-breast-cancer-in-women-with-severe-mental-illness-replication-of-a-nationwide-nested-casecontrol-database-study","Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness - Replication of a Nationwide Nested Case–Control Database Study","","Antipsychotics are essential for symptom remission in severe mental illness, but long-term safety remains a concern. Breast cancer appears more common in women with severe mental illness, and prolactin-increasing antipsychotics may contribute through hyperprolactinemia. Using Swedish nationwide registers, women aged 18–85 with severe mental illness and breast cancer were matched to non-cancer controls. Conditional logistic regression assessed cumulative exposure to prolactin-increasing versus prolactin-sparing antipsychotics. Results showed higher odds with prolactin-increasing exposure for 1–4 years and ≥5 years, with consistent sensitivity analyses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/antipsychotic-use-and-risk-of-breast-cancer-in-women-with-severe-mental-illness-replication-of-a-nationwide-nested-casecontrol-database-study/342093/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/antipsychotic-use-and-risk-of-breast-cancer-in-women-with-severe-mental-illness-replication-of-a-nationwide-nested-casecontrol-database-study/342093.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main hypothesis about breast cancer risk?","Question",{"text":112,"@type":113},"Breast cancer was hypothesized to be more prevalent in women with severe mental illness, potentially related to use of antipsychotics that increase prolactin.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the nested case–control study conducted?",{"text":117,"@type":113},"The study used Swedish nationwide registers and matched women with breast cancer to women without cancer by age, primary psychiatric diagnosis, and disease duration, then analyzed cumulative antipsychotic exposure with conditional logistic regression.",{"name":119,"@type":110,"acceptedAnswer":120},"What differences were found between prolactin-increasing and prolactin-sparing antipsychotics?",{"text":121,"@type":113},"Prolactin-increasing antipsychotic exposure was associated with increased odds of breast cancer for 1–4 years and ≥5 years, while prolactin-sparing exposure showed no increased (and no clear decreased) odds across those exposure windows.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342093,1790153087,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Schizophrenia Bulletin vol. 50 no. 6 pp. 1471–1481, 2024 [https://doi.org/10.1093/schbul/sbae058](https://doi.org/10.1093/schbul/sbae058)  \nAdvance Access publication November 1, 2024  \nAntipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case–Control Database Study  \nMarco Solmi1–5,, Markku Lähteenvuo6,, Antti Tanskanen6–8,, Olivier Corbeil9,10,, Ellenor Mittendorfer-Rutz7,, Christoph U Correll5,11,12,, Jari Tiihonen6–8,, and Heidi Taipale*,6–8,  \n1Department of Psychiatry, University of Ottawa, Ontario, Canada; 2SCIENCES LAB, Department of Mental Health, The  \nOttawa Hospital, Ontario, Canada; 3Ottawa Hospital Research Institute (OHRI), Clinical Epidemiology Program, University of Ottawa, Ontario, Canada; 4School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ontario, Canada; 5Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; 6Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; 7Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 8Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden; 9Faculty of Pharmacy, Université Laval, Quebec, Canada; 10Department of Pharmacy, Quebec Mental Health University Institute, Quebec, Canada; 11Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY; 12Department of Psychiatry and Molecular Medicine, Donald and Barbara School of Medicine at Hofstra/Northwell, Hempstead, NY  \n*To whom correspondence should be addressed; Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, 70240 Kuopio, Finland; [e-mail:](e-mail: heidi.taipale@uef.fi)[ heidi.taipale@uef.fi](e-mail: heidi.taipale@uef.fi)  \nBackground and hypothesis: Breast cancer is more prevalent in women with severe mental illness than in the general population, and use of prolactin-increasing antipsychotics may be a contributing factor. Study design: A nested case– control study was conducted using the Swedish nationwide registers (inpatient/outpatient care, sickness absence, disability pension, prescribed drugs, cancers). All women aged 18–85 years with schizophrenia/schizoaffective/other nonaffective psychotic disorder/bipolar disorder and breast cancer (cases) were matched for age, primary psychiatric diagnosis, and disease duration with five women without cancer (controls). The association between cumulative exposure to prolactin-increasing/prolactin-sparing antipsychotics and breast cancer was analyzed using conditional logistic regression, adjusted for comorbidities and co-medications. Study results: Among 132 061 women, 1642 (1.24%) developed breast cancer between 2010 and 2021, at a mean age of 63.3 ± 11.8 years. Compared with 8173 matched controls, the odds of breast cancer increased in women with prior exposure to prolactin-increasing antipsychotics for 1–4 years (adjusted odds ratio [aOR] = 1.20, 95% confidence interval [CI] = 1.03–1.41), and for ≥ 5 years (aOR = 1.47, 95%CI = 1.26–1.71). There were no increased or decreased odds of breast cancer with exposure to prolactin-sparing antipsychotics of either 1–4 years (aOR = 1.17, 95%CI = 0.98–1.40) or ≥5 years (aOR = 0.99, 95%CI = 0.78–1.26). The results were consistent across all sensitivity analyses (ie, according to different age groups, cancer types, and primary psychiatric diagnosis). Conclusions: Although causality remains  \nuncertain, exposure to prolactin-elevating antipsychotics for ≥ 1 year was associated with increased odds of breast cancer in women with severe mental illness. When prescribing antipsychotics, a shared decision-making process should consider individual risk factors for breast cancer.  \nKey words: prolactin/hyperprolactinemia/schizoaffective disorder/bipolar disorder/psychotic disorder/psychiatry  \nIntroduction  \nAntipsychotics are critical for symptom remission and recovery in p","cbCaitemtMLLdu6H","https://ap.wps.com/l/cbCaitemtMLLdu6H","pdf",564894,11,"English","# Background and hypothesis\n# Study design\n# Study results\n# Conclusions\n# Introduction","[{\"question\":\"What was the study’s main hypothesis about breast cancer risk?\",\"answer\":\"Breast cancer was hypothesized to be more prevalent in women with severe mental illness, potentially related to use of antipsychotics that increase prolactin.\"},{\"question\":\"How was the nested case–control study conducted?\",\"answer\":\"The study used Swedish nationwide registers and matched women with breast cancer to women without cancer by age, primary psychiatric diagnosis, and disease duration, then analyzed cumulative antipsychotic exposure with conditional logistic regression.\"},{\"question\":\"What differences were found between prolactin-increasing and prolactin-sparing antipsychotics?\",\"answer\":\"Prolactin-increasing antipsychotic exposure was associated with increased odds of breast cancer for 1–4 years and ≥5 years, while prolactin-sparing exposure showed no increased (and no clear decreased) odds across those exposure windows.\"}]","Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness - Replication of a Nationwide Nested Case–Control Database Study | PDF",1790045142,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd72eaf0145143a54bc0b055600039b0.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25a6f5b54f3adcdb816070f24340b36b.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdbebbf5869bd5f26adf116beaf7ea67.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86830698aa1c28b124c9d804a70ed112.webp",980,1292]